aveo pharmaceuticals inc
(AVEO:Consolidated Issue Listed on NASDAQ Global Select )
Lynda Chin M.D.
Member of Scientific Advisory Board, AVEO Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 48 board members in 3 different organizations across 4 different industries.|
See Board Relationships
Dr. Lynda Chin, MD served as a Scientific Co-Founder of Metamark Genetics, Inc. Dr. Chin co-founded Aveo Pharmaceuticals Inc. in 2002. She is the Chair of the Department of Genomic Medicine for Applied Cancer Science at the University of Texas MD Anderson Cancer Center. At the Broad Institute of Harvard and MIT, Dr. Chin is the PI of a TCGA Genome Data Analysis Center. She is actively involved in The Cancer Genes Atlas (TCGA) Project, a member of its Executive Subcommittee, ...
650 East Kendall StreetPhone: 617-299-5000
Cambridge, Massachusetts 02142
Board Members Memberships*
The University of Texas System
Albert Einstein College of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Paolo Pucci||Chief Executive Officer and Director|
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Yasuchika Hasegawa||Chairman and Chief Executive Officer|
Takeda Pharmaceutical Company Limited
|--||Compensation as of Fiscal Year 2013.|